Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis

Breast Cancer Research and Treatment

Volumn 138, Issue 2, 2013, Pages 519-528

  Batina, Nataliya G ^a   Trentham Dietz, Amy ^b,c   Gangnon, Ronald E ^b   Sprague, Brian L ^d   Rosenberg, Marjorie A ^b,e   Stout, Natasha K ^f   Fryback, Dennis G ^a,b   Alagoz, Oguzhan ^a,b,c  

^a University of Wisconsin Madison   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Black women; Breast cancer natural history; Racial disparities; Simulation model; White women

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CAUCASIAN; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; HEALTH DISPARITY; MAMMOGRAPHY; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; SIMULATION; TUMOR GROWTH; TUMOR VOLUME; UNITED STATES;

AFRICAN AMERICANS; BREAST NEOPLASMS; CALIBRATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; MODELS, BIOLOGICAL; NEOPLASM STAGING; SEER PROGRAM; TUMOR BURDEN; UNITED STATES;

EID: 84879419161     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2435-z     Document Type: Article

References (62)

1. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Thun M (2006) Trends in breast cancer by race and ethnicity: update. CA Cancer J Clin 56(3):168-183 (Pubitemid 43847927)
2. Ghafoor A, Jemal A, Cokkinides V, Cardinez C, Murray T, Samuels A, Thun MJ (2002) Cancer statistics for African Americans. CA Cancer J Clin 52(6):326-341 (Pubitemid 35446605)
3. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. (2011) SEER Cancer Statistics Review, 1975-2008, based on November 2010 SEER data submission, posted to the SEER web site (2011) National Cancer Institute. Bethesda, http://seer.cancer.gov/csr/1975-2008/. Accessed November 24, 2011
4. Miller BA, Hankey BF, Thomas TL (2002) Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am J Epidemiol 155(6):534-545 (Pubitemid 34208045)
5. Vastag B (2003) Breast cancer racial gap examined: no easy answers to explain disparities in survival. J Am Med Assoc 290(14):1838-1842. doi: 10.1001/jama.290.14.1838
6. Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1):49-56 (Pubitemid 36091600)
7. Shavers VL, Harlan LC, Stevens JL (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97(1):134-147. doi: 10.1002/cncr.11051 (Pubitemid 36033873)
8. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M (2003) Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53(6):342-355 (Pubitemid 38081592)
9. Newman LA (2005) Breast cancer in African-American women. Oncologist 10(1):1-14. doi: 10.1634/theoncologist.10-1-1
10. Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97(6):439-448. doi: 10.1093/jnci/dji064 (Pubitemid 40528607)
11. Amend K, Hicks D, Ambrosone CB (2006) Breast cancer in African-American women: differences in tumor biology from European-American women. Cancer Res 66(17):8327-8330. doi: 10.1158/0008-5472.CAN-06-1927 (Pubitemid 44449138)
12. Smith-Bindman R, Miglioretti DL, Lurie N, Abraham L, Barbash RB, Strzelczyk J, Dignan M, Barlow WE, Beasley CM, Kerlikowske K (2006) Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 144(8):541-553 (Pubitemid 46768143)
13. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. J Am Med Assoc 295(21):2492-2502. doi: 10.1001/jama.295.21.2492 (Pubitemid 43854964)
14. Vicini F, Jones P, Rivers A, Wallace M, Mitchell C, Kestin L, Jaiyesimi I, Dekhne N, Martinez A (2010) Differences in disease presentation, management techniques, treatment outcome, and toxicities in African-American women with early stage breast cancer treated with breast-conserving therapy. Cancer 116(14):3485-3492. doi: 10.1002/cncr.25088
15. DeSantis C, Jemal A, Ward E (2010) Disparities in breast cancer prognostic factors by race, insurance status, and education. Cancer Causes Control 21(9):1445-1450. doi: 10.1007/s10552-010-9572-z
16. Jazieh AR, Buncher CR (2002) Racial and age-related disparities in obtaining screening mammography: results of a statewide database. South Med J 95(10):1145-1148 (Pubitemid 35244831)
17. Elmore JG, Nakano CY, Linden HM, Reisch LM, Ayanian JZ, Larson EB (2005) Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care 43(2):141-148 (Pubitemid 40222632)
18. Peek ME, Han JH (2004) Disparities in screening mammography. Current status, interventions and implications. J Gen Intern Med 19(2):184-194
19. Yankaskas BC, Gill KS (2005) Diagnostic mammography performance and race: outcomes in black and white women. Cancer 104(12):2671-2681. doi: 10.1002/cncr.21550 (Pubitemid 41798277)
20. Wojcik BE, Spinks MK, Optenberg SA (1998) Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer 82(7):1310-1318. doi: 10.1002/(SICI)1097-0142(19980401)82: 7<1310:AID-CNCR14>3.0.CO;2-9 (Pubitemid 28155393)
21. Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, van Ravesteyn NT, Venier J, Zelen M, Feuer EJ (2009) Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 151(10):738-747. doi: 10.1059/0003-4819-151-10-200911170-00010
22. Demicheli R, Retsky MW, Hrushesky WJ, Baum M, Gukas ID, Jatoi I (2007) Racial disparities in breast cancer outcome: insights into host-tumor interactions. Cancer 110(9):1880-1888. doi: 10.1002/cncr.22998 (Pubitemid 350036847)
23. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA (2006) Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 24(9):1342-1349. doi: 10.1200/JCO.2005.03.3472 (Pubitemid 46621996)
24. Fryback DG, Stout NK, Rosenberg MA, Trentham-Dietz A, Kuruchittham V, Remington PL (2006) The Wisconsin breast cancer epidemiology simulation model. J Natl Cancer Inst Monogr 36:37-47. doi: 10.1093/jncimonographs/lgj007
25. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17):1784-1792. doi: 10.1056/NEJMoa050518 (Pubitemid 41549890)
26. Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG (2006) Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst 98(11):774-782. doi: 10.1093/jnci/djj210 (Pubitemid 43983301)
27. Tosteson AN, Stout NK, Fryback DG, Acharyya S, Herman BA, Hannah LG, Pisano ED (2008) Cost-effectiveness of digital mammography breast cancer screening. Ann Intern Med 148(1):1-10 (Pubitemid 351664941)
28. Holford TR, Cronin KA, Mariotto AB, Feuer EJ (2006) Changing patterns in breast cancer incidence trends. J Natl Cancer Inst Monogr 36:19-25. doi: 10.1093/jncimonographs/lgj016
29. Spratt JS, Spratt JA (2002) Growth rates. In: Donegan WL (ed) Cancer of the breast, 5th edn. Saunders, Philadelphia, pp 443-476
30. Cronin KA, Yu B, Krapcho M, Miglioretti DL, Fay MP, Izmirlian G, Ballard-Barbash R, Geller BM, Feuer EJ (2005) Modeling the dissemination of mammography in the United States. Cancer Causes Control 16(6):701-712. doi: 10.1007/s10552-005-0693-8 (Pubitemid 41110961)
31. Cronin KA, Mariotto AB, Clarke LD, Feuer EJ (2006) Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality. J Natl Cancer Inst Monogr 36:26-29. doi: 10.1093/jncimonographs/ lgj005
32. Mariotto AB, Feuer EJ, Harlan LC, Abrams J (2006) Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999. J Natl Cancer Inst Monogr 36:7-15. doi: 10.1093/jncimonographs/lgj003
33. United States Census Bureau Population Estimates (2008) http://www.census.gov/popest/archives/
34. Berkeley Mortality Database Data for the United States (2008) http://www.demog.berkeley.edu/~bmd/states.html
35. Centers for Disease Control and Prevention National Center for Health Statistics (2008) http://www.cdc.gov/nchs/
36. Software: Surveillance Research Program, National Cancer Institute SEER Stat software version 6.6.2. Available from: www.seer.cancer.gov/seerstat. Data: Surveillance, Epidemiology, and End Results (SEER) Program. Available from: www.seer.cancer.gov. SEER Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2009 Sub (1973-2007) < single ages to 85+, Katrina/Rita Population Adjustment > - Linked To County Attributes - Total U.S., 1969-2007 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission
37. Cronin KA, Miglioretti DL, Krapcho M, Yu B, Geller BM, Carney PA, Onega T, Feuer EJ, Breen N, Ballard-Barbash R (2009) Bias associated with self-report of prior screening mammography. Cancer Epidemiol Biomarkers Prev 18(6):1699-1705. doi: 10.1158/1055-9965.EPI-09-0020
38. Wasserman LA (2004) All of statistics: a conscise course in statistical inference. Springer texts in statistics, 1st edn. Springer, New York
39. Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, McCue P, Schwartz GF, Park PK, Rosenberg AL, Brill K, Mitchell EP (2007) Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer 110(4):876-884. doi: 10.1002/cncr.22836 (Pubitemid 47257667)
40. van Ravesteyn NT, Schechter CB, Near AM, Heijnsdijk EA, Stoto MA, Draisma G, de Koning HJ, Mandelblatt JS (2011) Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States. Cancer Epidemiol Biomarkers Prev 20(1):112-122. doi: 10.1158/1055-9965.EPI-10-0944
41. Joslyn SA (2002) Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res Treat 73(1):45-59 (Pubitemid 34548165)
42. McCullough ML, Feigelson HS, Diver WR, Patel AV, Thun MJ, Calle EE (2005) Risk factors for fatal breast cancer in African-American women and White women in a large US prospective cohort. Am J Epidemiol 162(8):734-742. doi: 10.1093/aje/kwi278 (Pubitemid 41437760)
43. Hall IJ, Moorman PG, Millikan RC, Newman B (2005) Comparative analysis of breast cancer risk factors among African-American women and White women. Am J Epidemiol 161(1):40-51. doi: 10.1093/aje/kwh331 (Pubitemid 40053278)
44. Fregene A, Newman LA (2005) Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American women? Cancer 103(8):1540-1550. doi: 10.1002/cncr.20978 (Pubitemid 40490014)
45. Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, Zhang B, Grushko T, Zhang C, Oluwasola O, Malaka D, Malami S, Odetunde A, Adeoye AO, Iyare F, Falusi A, Perou CM, Olopade OI (2009) Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 27(27):4515-4521. doi: 10.1200/JCO.2008.19.6873
46. Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999-2000. J Am Med Assoc 288(14):1723-1727
47. Cohen SS, Palmieri RT, Nyante SJ, Koralek DO, Kim S, Bradshaw P, Olshan AF (2008) Obesity and screening for breast, cervical, and colorectal cancer in women: a review. Cancer 112(9):1892-1904. doi: 10.1002/cncr.23408 (Pubitemid 351574064)
48. Elmore JG, Carney PA, Abraham LA, Barlow WE, Egger JR, Fosse JS, Cutter GR, Hendrick RE, D'Orsi CJ, Paliwal P, Taplin SH (2004) The association between obesity and screening mammography accuracy. Arch Intern Med 164(10):1140-1147. doi: 10.1001/archinte.164.10.1140 (Pubitemid 38668995)
49. Worthington J, Waterbor JW, Funkhouser E, Falkson C, Cofield S, Fouad M (2008) Receipt of standard breast cancer treatment by African American and White women. Int J Med Sci 5(4):181-188 (Pubitemid 352000030)
50. Keating NL, Kouri E, He Y, Weeks JC, Winer EP (2009) Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Med Care 47(7):765-773. doi: 10.1097/MLR.0b013e31819e1fe7
51. Curtis E, Quale C, Haggstrom D, Smith-Bindman R (2008) Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer 112(1):171-180. doi: 10.1002/cncr.23131
52. Shavers VL, Brown ML (2002) Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94(5):334-357 (Pubitemid 34257478)
53. Joslyn SA (2002) Racial differences in treatment and survival from early-stage breast carcinoma. Cancer 95(8):1759-1766. doi: 10.1002/cncr.10827
54. Fedewa SA, Ward EM, Stewart AK, Edge SB (2010) Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. J Clin Oncol 28(27):4135-4141. doi: 10.1200/JCO.2009.27.2427
55. Gorin SS, Heck JE, Cheng B, Smith SJ (2006) Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166(20):2244-2252. doi: 10.1001/archinte.166.20.2244 (Pubitemid 44748771)
56. Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA (2006) Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 24(9):1357-1362. doi: 10.1200/JCO.2005.04.5799 (Pubitemid 46621998)
57. Hershman D, McBride R, Jacobson JS, Lamerato L, Roberts K, Grann VR, Neugut AI (2005) Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 23(27):6639-6646. doi: 10.1200/JCO.2005.12.633 (Pubitemid 46190258)
58. Hershman DL, Unger JM, Barlow WE, Hutchins LF, Martino S, Osborne CK, Livingston RB, Albain KS (2009) Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897. J Clin Oncol 27(13):2157-2162. doi: 10.1200/JCO.2008.19.1163
59. Griggs JJ, Sorbero ME, Lyman GH (2005) Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med 165(11):1267-1273. doi: 10.1001/archinte.165.11.1267 (Pubitemid 40989591)
60. Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW (2003) Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat 81(1):21-31. doi: 10.1023/A:1025481505537 (Pubitemid 37108437)
61. Griggs JJ, Culakova E, Sorbero ME, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH (2007) Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. J Clin Oncol 25(3):277-284. doi: 10.1200/JCO.2006.08.3063 (Pubitemid 350010638)
62. Reding KW, Carlson CS, Kahsai O, Chen CC, McDavid A, Doody DR, Chen C, Ornelas I, Lowe K, Bernstein L, Weiss L, McDonald JA, Simon MS, Strom B, Marchbanks PA, Burkman R, Spirtas R, Liff JM, Malone KE (2012) Examination of ancestral informative markers and self-reported race with tumor characteristics of breast cancer among black and white women. Breast Cancer Res Treat 134(2):801-809. doi: 10.1007/s10549-012-2099-0